The purpose of this article is to provide treatment algorithms proven to be effective in meeting the standards of care of the American Diabetes Association to nurses and pharmacists who are given the authority to make independent clinical decisions (under the overall supervision of a physician).
Get full access to this article
View all access options for this article.
References
1.
American Diabetes Association.Standards of medical care in diabetes-2007. Diabetes Care . 2007;30(suppl 1):S4-S41.
2.
Davidson MBThe effectiveness of nurse- and pharmacist-directed care in diabetes disease management: a narrative review. Curr Diabetes Rev . 2007;3:280-286.
3.
LegorretaAP,Peters AL, Ossorio C., Lopez RJ, Jatulis D., Davidson MBEffect of a comprehensive nurse-managed diabetes program: an HMO study . Am J Manag Care. 1996;2:1024-1030.
4.
Peters AL, Davidson MBApplication of a diabetes managed care program: the feasibility of using nurses and a computer system to provide effective care. Diabetes Care. 1998;21:1037-1043.
5.
Davidson MB, Karlan VJ, Hair TLEffect of a pharmacist-managed diabetes care program in a free medical clinic . Am J Med Qual. 2000;15:137-142.
6.
Davidson MBEffect of nurse-directed diabetes care in a minority population. Diabetes Care. 2003;26:2281-2287.
7.
Davidson MB, Castellanos M., Duran P., Karlan V.Effective diabetes disease management for a poor and poorly educated minority population. Am J Manag Care. 2006 ;12:226-232.
Nathan DM, Buse JB, Davidson MB, et al. Management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy. Diabetes Care. 2006;29:1963-1972.
10.
Tran MT, Navar MD, Davidson MBComparison of the glycemic effects of rosiglitazone and pioglitazone in triple oral therapy in type 2 diabetes mellitus. Diabetes Care. 2006;29:1395-1396.
11.
Hermansen K. , Kipnes M., Luo E., Fanurik D., Khatami H., Stein P., for the Sitagliptin Study 035 Group.Efficacy and safety of the dipeptidyl peptidase-4 inhibitor, sitagliptin, in patients with type 2 diabetes mellitus inadequately controlled on glimepiride alone or on glimepiride and metformin. Diab Obes Metab. 2007;9:733-745.
12.
Skyler JSDiabetic complications: the importance of control. Endocrinol Metab Clin North Am. 1996;25:243-254.
13.
Krolewski AS , Laffel LMB, Krolewski M., et al. Glycosylated hemoglobin and the risk of microalbuminuria in patients with insulin-dependent diabetes mellitus. N Engl J Med. 1995;332: 1251-1255.
14.
Warram JH, Scott LJ, Hanna LS, et al. Progression of microalbuminuria to proteinuria in type 1 diabetes: nonlinear relationship with hyperglycemia. Diabetes. 2000;49:94-100.
15.
Ohkubo Y., Kishikawa H., Araki E., et al. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non insulin-dependent diabetes mellitus: a randomized prospective 6-year study. Diabetes Res Clin Pract. 1995;28:103-117.
16.
Tanaka Y., Atsumi Y., Matsuoka K., et al. Role of glycemic control and blood pressure in the development and progression of nephropathy in elderly Japanese NIDDM patients. Diabetes Care. 1998;21:116-120.
17.
Stults B., Jones REManagement of hypertension in diabetes. Diabetes Spectrum . 2006;19:25-31.
